| DRUG WATCH |
|
| Year : 2016 | Volume
: 48
| Issue : 2 | Page : 219-220 |
Acemetacin-induced fixed drug eruption
Filiz Cebeci1, Sirin Yasar1, Sema Aytekin1, Pembegul Gunes2
1 Department of Dermatology, Haydarpasa Numune Training and Research Hospital, Istanbul, Turkey
2 Department of Pathology, Haydarpasa Numune Training and Research Hospital, Istanbul, Turkey
Correspondence Address:
Filiz Cebeci
Department of Dermatology, Haydarpasa Numune Training and Research Hospital, Istanbul
Turkey
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0253-7613.178824
Fixed drug eruption (FDE) is an adverse effect observed with various drugs such as nonsteroidal anti-inflammatory drugs (NSAIDs) and various antibiotics. Acemetacin, a prodrug of indomethacin, is an NSAID licensed for use in rheumatic disease and other musculoskeletal disorders. We present a case of acemetacin-induced FDE in a 49-year-old woman. To the best of our knowledge, this is the second case report detailing clinical and histopathological findings of a patient with FDE caused by acemetacin.
[FULL TEXT] [PDF]*
|
